Director Jennifer McKie Adams sold 50,000 shares of ETON at $32.48 for $1,623,795.00; now holds 0 non-derivative shares.
Jennifer McKie Adams sold 50,000 shares on 2026-06-17 at $32.48, representing the entirety of her Table I holdings, for a total value of $1,623,795.00. The company's stock has appreciated 57.7% over the past 90 days and currently trades at $32.76, near its 52-week high of $35.66. Eton Pharmaceuticals has demonstrated strong revenue momentum with annual growth of +104.9% and generated net income of $1,554,000.00 in the latest quarter, though the company remains unprofitable on a full-year basis. This sale eliminates her non-derivative equity position while the stock remains near peak valuation levels against its 52-week range.